Lighthouse Labs

R&D

Alderley Park’s Mereside campus is at the forefront of the UK’s COVID-19 testing plans, playing a key role in the national Lighthouse Lab programme.

News

Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.